Literature DB >> 33326143

Withdrawn: L. Ma, T. Li, G. Liu, J. Wang, Z. Yin, J. Kang, LncRNA RHPN1-AS1 modulates cholangiocarcinoma progression and is related with poor clinical outcomes through miR-345-5p/YAP1 axis.

.   

Abstract

Entities:  

Year:  2022        PMID： 33326143     DOI： 10.1111/jgh.15374

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.369


× No keyword cloud information.
  2 in total

1.  The lncRNA DANCR promotes development of atherosclerosis by regulating the miR-214-5p/COX20 signaling pathway.

Authors:  Ruolan Zhang; Yuming Hao; Jinrong Zhang
Journal:  Cell Mol Biol Lett       Date:  2022-02-17       Impact factor: 5.787

2.  LINC00630 promotes cholangiocarcinoma cell proliferation, migration and invasion by mediating the miR-199a/FGF7 axis.

Authors:  Baiyin Zhong; Caixin Song; Qingfang He; Zhixi Chen; Qicheng Liao; Qiusheng Xiong; Shijie Wang; Yuansheng Xiao; Xing Xie; Yuankang Xie; Xiaonong Wang; Jianhong Zhang
Journal:  J Cancer       Date:  2022-01-04       Impact factor: 4.207
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.